InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Stein Steven H, Directeur Médical. Director active across 1 companies, notably INCYTE CORP. Cumulatively, 9 filings have been recorded. The latest transaction was disclosed on 28 June 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is free.
Declarations9 total
€825,61311,488 shares@ €71.86740.0043% mcap20.7% of flow
Common Stock
SEC:0001209191-22-039904:0·
028,926 shares0
Common Stock
SEC:0001209191-22-001670·
028,926 shares0
Common Stock
SEC:0001209191-22-001670:0·
0379 shares0
Common Stock
SEC:0001209191-21-066430·
0379 shares0
Common Stock
SEC:0001209191-21-066430:0·
07,853 shares0
Common Stock
SEC:0001209191-21-045888·
07,853 shares0
Common Stock
SEC:0001209191-21-045888:0·
€2m22,079 shares@ €71.76690.0083% mcap100.0% of flow
Common Stock
SEC:0001209191-21-043978·
€2m22,079 shares@ €71.76690.0083% mcap39.7% of flow
Common Stock
SEC:0001209191-21-043978:0·
9 of 9 declarations
About Stein Steven H
Stein Steven H serves as Executive Vice President and Chief Medical Officer at Incyte Corp. In this role, he is responsible for the company's medical strategy and research initiatives. His expertise in biotechnology enables him to lead teams in developing new treatments. He plays a crucial role in guiding Incyte's research and development efforts.
